The hire comes as the San Francisco company expands globally, including its recent purchase of an Australian telehealth firm ...

Check out the companies making headlines before the bell. Bumble — Bumble shares popped about 21% after the dating app ...

Hims & Hers Health (HIMS) is rated a Speculative Buy after its renewed partnership with Novo Nordisk, providing legitimate ...

Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a ...

Telehealth company Hims & Hers on Monday announced a “strategic shift” in its business model, partnering with pharmaceutical ...

Hims & Hers Health (NYSE:HIMS) looked like a fallen growth star earlier this year. The telehealth platform was hammered by the FDA’s aggressive crackdown on compounded GLP-1 drugs, complete with ...

On March 12, 2026, investors weighed profit-taking against a high-stakes pivot toward branded obesity drugs and telehealth growth.

Hims & Hers Health, Inc.'s revenue is projected to reach $2.7B in 2026 & $3.2B in 2027, implying less than 2x forward sales. Read more on HIMS stock here.

Yahoo Finance anchor Josh Lipton tracks Wednesday's top moving stocks and biggest market stories in this Market Minute. Hims ...

Hims & Hers Health (HIMS) reached $2.347 billion in full-year revenue, up 59% year-over-year, with a subscriber base crossing 2.5 million and monthly revenue per subscriber at $83. Progyny (PGNY) ...

Hims & Hers Health has hired Eli Lilly and Company’s former head of communications Kathryn Beiser to be its chief communications officer. Beiser started in the role last month, according to her ...

Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stocks Making Huge Moves Today. Hims & Hers extended its winning streak to a third consecutive day on Wednesday, jumping 10.27 percent to close at ...